• Radioiodinated Balsalazide: A Selective Radiotracer for Ulce

  2026-06-25

  This study introduces a robust protocol for radioiodinating balsalazide, producing a highly selective radiotracer for imaging ulcerative colitis in mice. The findings demonstrate high stability, target organ specificity, and practical advantages over conventional imaging for preclinical inflammation research.

• DOT1L Inhibition Amplifies Lenalidomide Response in Myeloma

  2026-06-25

  The referenced study identifies DOT1L as a critical epigenetic dependency in multiple myeloma and shows that its inhibition reprograms innate immunity, thereby potentiating the efficacy of immunomodulatory drugs such as lenalidomide. This mechanistic insight suggests new combinatorial strategies to overcome resistance and improve therapeutic outcomes in myeloma research.

• Recombinant Mouse M-CSF (PM2021): Mechanism, Evidence & Limi

  2026-06-24

  Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag (PM2021) is a validated reagent for macrophage survival and proliferation assays. Its rigorously characterized potency and specificity make it essential for studies of osteoclast progenitor proliferation and macrophage-mediated inflammatory modulation. This dossier details its mechanism, evidence base, and practical boundaries for research use.

• Ibrexafungerp Efficacy Against Fluconazole-Resistant C. auri

  2026-06-23

  This study demonstrates that ibrexafungerp (MK 3118), a novel oral triterpenoid, exhibits potent in vitro and in vivo efficacy against fluconazole-resistant Candida auris. The findings support ibrexafungerp as a promising therapeutic for invasive candidiasis, particularly in the context of delayed treatment initiation and antifungal resistance.

• Nelfinavir Mesylate: Bridging HIV Inhibition and Ferroptosis

  2026-06-23

  Explore how Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, is redefining translational research by linking antiretroviral strategies with the modulation of regulated cell death pathways like ferroptosis. This article delivers mechanistic insights, workflow guidance, and a forward-thinking perspective for researchers pursuing next-generation therapies and cell biology breakthroughs.

• Pomalidomide (CC-4047) in Multiple Myeloma Research Workflow

  2026-06-22

  Pomalidomide (CC-4047) delivers distinct advantages for hematological malignancy research by combining potent immunomodulatory and antineoplastic activities. This article translates recent mutational landscape findings into actionable protocols, troubleshooting strategies, and advanced applications for optimized multiple myeloma and erythroid progenitor cell experimentation.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Application Guide for

  2026-06-22

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for specific and reproducible detection of HMGB1 protein in human, mouse, and rat samples. It is optimized for scientific research applications, supporting workflows such as Western blot, immunohistochemistry, and flow cytometry, but is not intended for diagnostic or clinical use.

• MMP-2 Responsive Liposomes Enable Sequential Immunotherapy i

  2026-06-21

  This study introduces an intelligent, MMP-2-responsive dual-targeting liposomal system for the sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor in breast cancer. The approach remodels the immunosuppressive tumor microenvironment, resulting in improved T cell reactivation and reduced toxicity, with implications for advancing combination immunotherapy.

• Ibrexafungerp in Acidic Environments: Redefining Antifungal

  2026-06-20

  Discover how Ibrexafungerp (MK 3118) stands apart as an oral antifungal uniquely effective in acidic environments, supporting robust assay development and therapy for resistant Candida. This article delivers a deep mechanistic perspective and practical guidance for leveraging Ibrexafungerp’s properties, bridging clinical and research needs.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Use Guide

  2026-06-19

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for specific and reliable detection of HMGB1 protein in human, mouse, and rat research workflows, including Western blot, immunohistochemistry, and flow cytometry. It is solely intended for scientific research, not for diagnostic or therapeutic use, and requires careful application-specific protocol adherence for optimal results.

• Radioiodinated Balsalazide Disodium as a Selective UC Radiot

  2026-06-19

  Sanad et al. have developed and characterized a radioiodinated form of balsalazide disodium, demonstrating its high selectivity and stability as a radiotracer for imaging ulcerative colitis (UC) in murine models. This work advances both mechanistic understanding and preclinical imaging capabilities for inflammatory bowel disease research.

• Precision Phosphorylation Preservation: A New Era for Transl

  2026-06-18

  This thought-leadership article explores the mechanistic, strategic, and translational importance of precise protein phosphorylation preservation, with a focus on APExBIO’s Phosphatase Inhibitor Cocktail 1 (100X in DMSO). By integrating insights from recent single-cell cardiac research and phosphoproteomic advances, the piece provides practical guidance for researchers seeking to decode cellular signaling and unlock new therapeutic opportunities.

• Crystal Violet Staining Solution: Decoding Biofilm and Nucle

  2026-06-18

  Explore the scientific depth of Crystal Violet Staining Solution as a nuclear staining dye and its critical use in dissecting biofilm and cell population dynamics. This article uniquely connects molecular epidemiology insights with assay optimization for advanced research.

• Hydroxychloroquine Sulfate Use in Autoimmune Disease Researc

  2026-06-17

  Hydroxychloroquine Sulfate (SKU B4874) addresses the need for precise inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, especially for systemic lupus erythematosus and rheumatoid arthritis models. It is best suited to workflows using aqueous solutions and is not appropriate for protocols requiring organic solvent solubility or extended solution storage.

• Hydroxychloroquine Sulfate: Technical Guide for Autoimmune M

  2026-06-17

  Hydroxychloroquine Sulfate (SKU B4874) provides a reliable solution for researchers targeting autophagy and TLR7/9 signaling pathways in autoimmune disease research. It is suitable for aqueous-based workflows and short-term studies, but is not appropriate for protocols requiring organic solvents or long-term solution storage.

16100 records 1/1074 page Next 12345 下5页 Last page